We are live on ! Find out more
ABMD

Abiomed Inc
ABMD

Delisted

ABMD was delisted on the 21st of December, 2022.

Back to rankings

527 hedge funds and large institutions have $16B invested in Abiomed Inc in 2018 Q2 according to their latest regulatory filings, with 153 funds opening new positions, 157 increasing their positions, 171 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

428% more first-time investments, than exits

New positions opened: 153 | Existing positions closed: 29

40% more funds holding in top 10

Funds holding in top 10: 15 → 21 (+6)

40% more capital invested

Capital invested by funds: $11.5B → $16B (+$4.55B)

30% more funds holding

Funds holding: 405 → 527 (+122)

8% less repeat investments, than reductions

Existing positions increased: 157 | Existing positions reduced: 171

21% less call options, than puts

Call options by funds: $167M | Put options by funds: $212M

Holders
527
Holders Change
+122
Holders Change %
+30.12%
% of All Funds
12.07%
Holding in Top 10
21
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+40%
% of All Funds
0.48%
New
153
Increased
157
Reduced
171
Closed
29
Calls
$167M
Puts
$212M
Net Calls
-$45.4M
Net Calls Change
-$39.3M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$297M
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$210M
3
State Street
State Street
Massachusetts
+$158M
4
Renaissance Technologies
Renaissance Technologies
New York
+$146M
5
Two Sigma Investments
Two Sigma Investments
New York
+$138M

Top Sellers

1
BlackRock
BlackRock
New York
-$315M
2
Winslow Capital Management
Winslow Capital Management
Minnesota
-$284M
3
PAI
Palo Alto Investors
California
-$165M
4
William Blair Investment Management
William Blair Investment Management
Illinois
-$154M
5
American Century Companies
American Century Companies
Missouri
-$136M
Name Holding Trade Value Shares
Change 		Change in
Stake
PAM
326
Panagora Asset Management
Massachusetts
$920K +$815K +2,249 New
CWM
327
Cabot Wealth Management
Massachusetts
$911K – – –
PCAP
328
Pratt Collard Advisory Partners
New York
$900K – – –
WCM
329
Whitener Capital Management
North Carolina
$889K -$109K -300 -12%
FRM
330
Fox Run Management
Connecticut
$881K +$780K +2,153 New
ECM
331
ETrade Capital Management
Virginia
$876K +$776K +2,142 New
CAN
332
Claraphi Advisory Network
United States
$859K +$17.4K +48 +2%
TC
333
Telemus Capital
Michigan
$851K – – –
WSTAM
334
Wilbanks Smith & Thomas Asset Management
Virginia
$850K -$107K -294 -12%
Janney Montgomery Scott
335
Janney Montgomery Scott
Pennsylvania
$834K +$104K +286 +16%
PPCM
336
Pillar Pacific Capital Management
California
$824K +$14.5K +40 +2%
Stifel Financial
337
Stifel Financial
Missouri
$819K -$25.7K -71 -3%
RA
338
Royce & Associates
New York
$818K -$2.9M -8,000 -80%
Rafferty Asset Management
339
Rafferty Asset Management
New York
$813K +$720K +1,987 New
Pacer Advisors
340
Pacer Advisors
Pennsylvania
$807K -$3.45M -9,512 -83%
Envestnet Asset Management
341
Envestnet Asset Management
Illinois
$803K -$7.25K -20 -1%
JIP
342
Jaffetilchin Investment Partners
Florida
$802K +$710K +1,960 New
Nordea Investment Management
343
Nordea Investment Management
Sweden
$783K -$3.2M -8,845 -82%
II
344
IFM Investors
Australia
$765K +$677K +1,869 New
FHA
345
Flagship Harbor Advisors
Massachusetts
$762K +$224K +618 +50%
GIA
346
Gateway Investment Advisers
Ohio
$750K +$664K +1,834 New
BRWA
347
B. Riley Wealth Advisors
Florida
$747K -$1.81K -5 -0.3%
MC
348
Moors & Cabot
Massachusetts
$746K +$14.5K +40 +2%
CA
349
Commerzbank Aktiengesellschaft
Germany
$740K +$655K +1,809 New
RI
350
Redwood Investments
Massachusetts
$736K -$2.01M -5,553 -76%
12 13
14
15 16

ABMD Hedge Fund Activity: Q2 2018 in Review

527 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q2 2018, worth a combined $16B — up 40% from $11.5B a quarter earlier.

Buyers outnumbered sellers: 153 funds opened new ABMD positions and 29 closed out — a net gain of 124 holders — while 157 added to existing stakes and 171 trimmed.

The largest buyer was Vanguard Group, adding an estimated $297M. The largest seller was BlackRock, cutting an estimated $315M.

  • 527 institutional investors held Abiomed Inc (ABMD) as of Q2 2018, up from 405 in Q1 2018.
  • Funds reported $16B of Abiomed Inc stock for Q2 2018, up 40% quarter-over-quarter.
  • 153 funds opened new Abiomed Inc positions in Q2 2018 and 29 closed out, a net change of +124 holders.
  • The largest Abiomed Inc buyer in Q2 2018 was Vanguard Group, an estimated $297M added.
  • The largest Abiomed Inc seller in Q2 2018 was BlackRock, an estimated $315M sold.

Based on aggregated 13F filings for Q2 2018.